Press Release | Tissuepathology.com

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Erica Goodpaster — Fri, 19 Jun 2026 12:16:28 +0000

Charles River and Lilly Tune Lab: Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab was created to […]

The post Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise first appeared on Tissuepathology.com.

Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists

Erica Goodpaster — Thu, 18 Jun 2026 15:22:57 +0000

PHILADELPHIA — June 17, 2026 — Proscia® today introduced the Fifth Generation of its Concentriq®[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies. Pathology sits […]

The post Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists first appeared on Tissuepathology.com.

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Erica Goodpaster — Wed, 17 Jun 2026 11:42:11 +0000

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated with faster disease progression and reduced benefit from current standard-of-care treatments.1 The FDA approval reinforces Roche’s leadership […]

The post Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer first appeared on Tissuepathology.com.

Leica Biosystems Launches AI-Powered Digital Pathology Solution in Europe, Middle East, and Africa

Erica Goodpaster — Tue, 16 Jun 2026 13:32:41 +0000

Leica Biosystems: High-throughput Aperio GT Elite scanner with AI-enabled quality control supports digital and computational pathology workflows VISTA, CA – June 15, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, is expanding the availability of its Aperio GT Elite digital scanner into the EMEA (Europe, Middle East & […]

The post Leica Biosystems Launches AI-Powered Digital Pathology Solution in Europe, Middle East, and Africa first appeared on Tissuepathology.com.

Aiforia Announces Webinar

Erica Goodpaster — Mon, 15 Jun 2026 13:28:15 +0000

Join Aiforia for a webinar later this month. Pathologist and AI: A Collaboration in Practice Monday, June 29th, 2026 | 4:00 pm CEST | 5:00 pm EEST | 10:00 am EDT Register Now Even the most accurate AI models only fulfill their full potential when they fit seamlessly into a pathologist’s daily practice. That’s why […]

The post Aiforia Announces Webinar first appeared on Tissuepathology.com.

Aiforia expands its presence in Spain through a new clinical account

Erica Goodpaster — Fri, 12 Jun 2026 12:48:19 +0000

Aiforia has been selected via a public tender, won by Palex, to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. Aiforia Technologies Plc, Press Release, June 11, 2026 at 9:30 a.m. EEST Aiforia Technologies has been selected to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. The […]

The post Aiforia expands its presence in Spain through a new clinical account first appeared on Tissuepathology.com.